Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9786209048579
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9786209048579
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The prevalence of Crohn's disease (CD), a chronic and life-threatening inflammatory bowel disease (IBD), is steadily increasing worldwide. A shift to personalized medicine is required because CD is a very heterogeneous disease that poses ongoing challenges in prognosis and treatment selection. The crucial and quickly developing field of disease prognosis receives a significant amount of attention. In addition to examining markers for predicting disease course and the growing potential of proteomics for forecasting disease activity and treatment response, the book goes beyond conventional evaluations to emphasize the clinical significance of biomarkers in CD. Finally, the book offers an exhaustive review of potential factors associated with the progression of CD and the current medical treatments guiding toward effective, personalized patient management. 80 pp. Englisch. N° de réf. du vendeur 9786209048579
Quantité disponible : 2 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The prevalence of Crohn's disease (CD), a chronic and life-threatening inflammatory bowel disease (IBD), is steadily increasing worldwide. A shift to personalized medicine is required because CD is a very heterogeneous disease that poses ongoing challenges in prognosis and treatment selection. The crucial and quickly developing field of disease prognosis receives a significant amount of attention. In addition to examining markers for predicting disease course and the growing potential of proteomics for forecasting disease activity and treatment response, the book goes beyond conventional evaluations to emphasize the clinical significance of biomarkers in CD. Finally, the book offers an exhaustive review of potential factors associated with the progression of CD and the current medical treatments guiding toward effective, personalized patient management. N° de réf. du vendeur 9786209048579
Quantité disponible : 1 disponible(s)
Vendeur : Books Puddle, Woodside, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26405629329
Quantité disponible : 4 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 408606286
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND. N° de réf. du vendeur 18405629339
Quantité disponible : 4 disponible(s)
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. The prevalence of Crohn's disease (CD), a chronic and life-threatening inflammatory bowel disease (IBD), is steadily increasing worldwide. A shift to personalized medicine is required because CD is a very heterogeneous disease that poses ongoing challenges in prognosis and treatment selection. The crucial and quickly developing field of disease prognosis receives a significant amount of attention. In addition to examining markers for predicting disease course and the growing potential of proteomics for forecasting disease activity and treatment response, the book goes beyond conventional evaluations to emphasize the clinical significance of biomarkers in CD. Finally, the book offers an exhaustive review of potential factors associated with the progression of CD and the current medical treatments guiding toward effective, personalized patient management. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9786209048579
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The prevalence of Crohn's disease (CD), a chronic and life-threatening inflammatory bowel disease (IBD), is steadily increasing worldwide. A shift to personalized medicine is required because CD is a very heterogeneous disease that poses ongoing challenges in prognosis and treatment selection. The crucial and quickly developing field of disease prognosis receives a significant amount of attention. In addition to examining markers for predicting disease course and the growing potential of proteomics for forecasting disease activity and treatment response, the book goes beyond conventional evaluations to emphasize the clinical significance of biomarkers in CD. Finally, the book offers an exhaustive review of potential factors associated with the progression of CD and the current medical treatments guiding toward effective, personalized patient management.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 80 pp. Englisch. N° de réf. du vendeur 9786209048579
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Emerging Approaches in Crohn's Disease | Crohn's Disease: Pathogenesis and Prognostic Biomarkers with Precision Therapeutics | Dalia Medhat | Taschenbuch | Englisch | 2025 | LAP LAMBERT Academic Publishing | EAN 9786209048579 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu. N° de réf. du vendeur 134204698
Quantité disponible : 5 disponible(s)